Products for Research Use Only
RegisterLogin

ALD1613

CAT: 0804-HY-P991221Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991221Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ALD1613 is a potent neutralizing monoclonal antibody against adrenocorticotropic hormone (ACTH) . ALD1613 neutralizes ACTH-induced signaling and inhibits ACTH-induced cyclic AMP accumulation in a mouse adrenal cell line (Y1) via all five melanocortin receptors. ALD1613 significantly reduces plasma corticosterone levels in wild-type rats. ALD1613 can be used in the study of diseases associated with elevated ACTH levels[1].
UNSPSC
12352203
Target
Melanocortin Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Smiles
[ALD1613]
References & Citations
[1]Andrew L Feldhaus, et al. ALD1613, a Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven Pharmacology. Endocrinology. 2017 Jan 1;158 (1) :1-8.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P991511-01ALD1910

Alternative Products

CatalogName
T9901A-967-01ALD1613
PTX25449-01Anti-Human ACTH (ALD1613)
MBS1581783-01Research Grade Anti-Human ACTH (ALD1613)
A135707Anti-ACTH (ALD1613) Biosimilar (Monoclonal, IgG1-kappa)

Popular Products